To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.
Biomanufacturing company Multiply Labs is using Nvidia technologies to develop robotic biomanufacturing systems for ...
16d
Multiply Labs to Bring "Physical AI" Robotics Technology to Advanced Biomanufacturing With NVIDIA
Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...
AstraZeneca collaborates with Multiply Labs to scale cell therapy manufacturing using end-to-end GMP-ready robotic technology ...
Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.
Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...
Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA’s open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results